WestRock Co., Norcross, Ga., USA, this week announced that D. Michael Wilson will be CEO of the company's specialty chemicals business that is expected to become a publicly traded company, Ingevity, early next year as a result of a spin-off from WestRock. He will join the company at the beginning of next month (September 1).

"Michael Wilson brings breadth and depth of specialty chemicals experience to Ingevity," said Steve Voorhees, CEO of WestRock. "His exceptional leadership skills and outstanding track record of delivering results will serve Ingevity and its stockholders well."

Michael comes to Ingevity from Albemarle Corp. where he most recently served as EVP, leading Albemarle's Performance Chemicals business. Prior to that, he led Albemarle's Catalyst Solutions business and held a variety of business unit leadership roles at FMC, Wausau Papers, and Rexam. He holds a B.S. degree in chemistry from the University of North Carolina and a MBA degree from the Kenan-Flagler Business School at the University of North Carolina.